-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Brokerages
Source: Buzz FX / 19 Mar 2025 01:41:16 America/Chicago
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Crinetics Pharmaceuticals, Inc.
Read more...